Viewing Study NCT06232551

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:40 PM
Ignite Modification Date: 2026-02-24 @ 5:02 PM
Study NCT ID: NCT06232551
Status: RECRUITING
Last Update Posted: 2024-07-17
First Post: 2024-01-18
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism
Sponsor: Scott C. Woller, MD
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Venous Thromboembolic Disease View
None Pulmonary Embolism and Thrombosis View
None Deep Vein Thrombosis View
None Hospitalism View
Keywords:

Keywords

Keyword Brief Keyword Text View
None post-discharge View
None extended duration thromboprophylaxis View
None rivaroxaban View
None direct oral anticoagulant View
None medical patient View